Beck Bode, LLC Astrazeneca PLC Transaction History
Beck Bode, LLC
- $572 Million
- Q3 2025
A detailed history of Beck Bode, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Beck Bode, LLC holds 223,543 shares of AZN stock, worth $20 Million. This represents 3.0% of its overall portfolio holdings.
Number of Shares
223,543
Previous 216,433
3.29%
Holding current value
$20 Million
Previous $15.1 Million
13.4%
% of portfolio
3.0%
Previous 2.81%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...